Share Price | Heart Test Laboratories, Inc. Stock Analysis & Recommendation

Q: How big is Heart Test Laboratories, Inc.?

Market Cap: As of Jun 18, Heart Test Laboratories, Inc. has a market capitalization of 4.02 million, categorizing it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters, Heart Test Laboratories, Inc. reported net sales of 0.00 million and a net profit of -8.52 million.Balance Sheet Snapshot: As of Apr 24, the company reported shareholder's funds of 7.32 million and total assets of 9.50 million.

Q: What does Heart Test Laboratories, Inc. do?

Overview: Heart Test Laboratories, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.Financial Snapshot: Net Profit: -3 Million (Quarterly Results - Jan 2025) Market Cap: USD 4.02 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: 0.03 Return on Equity: -465.37% Price to Book: 2.25Contact Details: Registrar Address: Not available.

Q: Is Heart Test Laboratories, Inc. technically bullish or bearish?

As of 11 September 2025, the technical trend for Heart Test Laboratories, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across different indicators. The weekly MACD is bearish, while the monthly MACD is mildly bullish. The weekly Bollinger Bands indicate a mildly bearish trend, and the Dow Theory shows a mildly bearish stance on the weekly timeframe. However, the daily moving averages are mildly bullish, and the On-Balance Volume (OBV) is bullish for both weekly and monthly periods. In terms of returns, the stock has outperformed the S&P 500 over the past week with a return of 5.39% compared to 1.05%, but it has underperformed over the past month and year-to-date. Overall, the mixed indicators suggest a lack of clear direction.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

44.76 k

Shareholding (Oct 2025)

FII

0.06%

Held by 4 FIIs

DII

99.41%

Held by 1 DIIs

Promoter

0.00%

How big is Heart Test Laboratories, Inc.?

22-Jun-2025

As of Jun 18, Heart Test Laboratories, Inc. has a market capitalization of 4.02 million, categorizing it as a Micro Cap company, with net sales of 0.00 million and a net profit of -8.52 million over the latest four quarters. The company reported shareholder's funds of 7.32 million and total assets of 9.50 million as of Apr 24.

View full answer

What does Heart Test Laboratories, Inc. do?

22-Jun-2025

Heart Test Laboratories, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $3 million and a market cap of $4.02 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -465.37%.

View full answer

Is Heart Test Laboratories, Inc. technically bullish or bearish?

20-Sep-2025

As of September 11, 2025, Heart Test Laboratories, Inc. shows a neutral technical trend with mixed signals, including a bearish weekly MACD and mildly bullish daily moving averages, while outperforming the S&P 500 over the past week but underperforming over the past month and year-to-date.

View full answer

Compare Heart Test Laboratories, Inc. with Similar Stocks

Bluejay Diagnostics, Inc.GlucoTrack, Inc.Helius Medical Technologies, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 12 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.32

Return on Equity

-216.05%

Price to Book

2.78

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Oct 2025)

Net Profit:

-2 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

7.55%

6 Months

-25.81%

1 Year

-47.08%

2 Years

-97.07%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Heart Test Laboratories, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

-144.47%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.03

Sales to Capital Employed (avg)

0.00

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

8.36%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.17

EV to EBIT

-0.47

EV to EBITDA

-0.48

EV to Capital Employed

2.14

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-453.86%

ROE (Latest)

-465.37%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Oct 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (0.53%)

Foreign Institutions

Held by 4 Foreign Institutions (0.06%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Oct'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Oct 2025 is 0.00% vs 0.00% in Oct 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Oct 2025 is -14.29% vs -23.53% in Oct 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Oct'25",
        "Oct'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.00",
          "val2": "-2.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.10",
          "chgp": "200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.40",
          "val2": "-2.10",
          "chgp": "-14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-857,132.30%",
          "val2": "0.00%",
          "chgp": "-85,713.23%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Apr'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Apr 2025 is 0.00% vs 0.00% in Apr 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Apr 2025 is -33.33% vs -3.13% in Apr 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Apr'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.20",
          "val2": "-6.20",
          "chgp": "-32.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.40",
          "chgp": "25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.80",
          "val2": "-6.60",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,920,131.30%",
          "val2": "-339,019.90%",
          "chgp": "-1,58,111.14%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Oct'25 - YoY

Oct'25

Oct'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-2.00

Interest

0.30

0.10

200.00%

Exceptional Items

0.00

Consolidate Net Profit

-2.40

-2.10

-14.29%

Operating Profit Margin (Excl OI)

-857,132.30%

0.00%

-85,713.23%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Oct 2025 is 0.00% vs 0.00% in Oct 2024

Consolidated Net Profit

YoY Growth in quarter ended Oct 2025 is -14.29% vs -23.53% in Oct 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Apr'25

Apr'25

Apr'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-8.20

-6.20

-32.26%

Interest

0.50

0.40

25.00%

Exceptional Items

0.00

0.10

-100.00%

Consolidate Net Profit

-8.80

-6.60

-33.33%

Operating Profit Margin (Excl OI)

-1,920,131.30%

-339,019.90%

-1,58,111.14%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Apr 2025 is 0.00% vs 0.00% in Apr 2024

Consolidated Net Profit

YoY Growth in year ended Apr 2025 is -33.33% vs -3.13% in Apr 2024

All Annual Results

Company CV

About Heart Test Laboratories, Inc.

Heart Test Laboratories, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Heart Test Laboratories, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Heart Test Laboratories, Inc.?

Watch in Real-Time

What does Heart Test Laboratories, Inc. do?

Is Heart Test Laboratories, Inc. technically bullish or bearish?

Compare Heart Test Laboratories, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Oct 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Oct'25 - YoY

Annual Results Snapshot (Consolidated) - Apr'25

About Heart Test Laboratories, Inc.

Company Coordinates